Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.

被引：0
|
作者：
Amit Patel
Umeer Waheed
Stephen J. Brett
机构：
[1] Hammersmith Hospital,Centre for Perioperative Medicine and Critical Care Research, General Intensive Care Unit
[2] Imperial College Healthcare NHS Trust,MRC Clinical Sciences Centre and Centre for Haematology
[3] Imperial College London,undefined
[4] Hammersmith Hospital,undefined
来源：
Intensive Care Medicine | 2013年 / 39卷
关键词：
Severe Sepsis; Eligibility Criterion; Primary Outcome Measure; Volume Expansion; Randomise Clinical Trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1507 / 1508
页数：1
相关论文
共 46 条
  • [1] Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
    Patel, Amit
    Waheed, Umeer
    Brett, Stephen J.
    [J]. INTENSIVE CARE MEDICINE, 2013, 39 (08) : 1507 - 1508
  • [2] Is 6% tetrastarch 130 kDa (hydroxyethyl starch 130/0.4 or 130/0.42) suitable for severe sepsis?
    Patel, Amit
    Brett, Stephen J.
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (03) : 178 - 178
  • [3] Bioequivalence comparison between hydroxyethyl starch 130/0.42/6: 1 and hydroxyethyl starch 130/0.4/9: 1
    Lehmann G.
    Marx G.
    Förster H.
    [J]. Drugs in R & D, 2007, 8 (4) : 229 - 240
  • [4] Evaluation of effectiveness and safety of hydroxyethyl starch (HES 130 kDa/0.4) in burn resuscitation
    A Mokline
    I Rahmani
    L Gharsallah
    H Oueslati
    B Gasri
    I Harzallah
    A Ksontini
    A Messadi
    [J]. Critical Care, 16 (Suppl 1):
  • [5] Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis
    Patel, Amit
    Waheed, Umeer
    Brett, Stephen J.
    [J]. INTENSIVE CARE MEDICINE, 2013, 39 (05) : 811 - 822
  • [6] Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis
    Amit Patel
    Umeer Waheed
    Stephen J. Brett
    [J]. Intensive Care Medicine, 2013, 39 : 811 - 822
  • [7] Equal effects of gelatin and hydroxyethyl starch (6% HES 130/0.42) on modified thrombelastography in children
    Osthaus, W. A.
    Witt, L.
    Johanning, K.
    Boethig, D.
    Winterhalter, M.
    Huber, D.
    Heimbucher, C.
    Suempelmann, R.
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2009, 53 (03) : 305 - 310
  • [8] Influence of hydroxyethyl starch (6% HES 130/0.4) administration on hematology and clinical chemistry parameters
    Mueller, Thomas
    Schimetta, Wolfgang
    Dieplinger, Benjamin
    Loeffler, Peter
    Rehm, Markus
    Kreimeier, Uwe
    Poelz, Werner
    Haltmayer, Meinhard
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2008, 46 (04) : 558 - 562
  • [9] Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review
    Hartog, Christiane S.
    Reuter, Dorit
    Loesche, Wolfgang
    Hofmann, Michael
    Reinhart, Konrad
    [J]. INTENSIVE CARE MEDICINE, 2011, 37 (11) : 1725 - 1737
  • [10] Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review
    Christiane S. Hartog
    Dorit Reuter
    Wolfgang Loesche
    Michael Hofmann
    Konrad Reinhart
    [J]. Intensive Care Medicine, 2011, 37 : 1725 - 1737
12345